These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 6185577)
1. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. Goto T; Herberman RB; Maluish A; Strong DM J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577 [TBL] [Abstract][Full Text] [Related]
2. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP. Lanefelt F; Ullberg M; Jondal M; Fredholm BB Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136 [TBL] [Abstract][Full Text] [Related]
3. Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity. Bancu AC; Gherman M; Sulica A; Goto T; Farrar W; Herberman RB Cell Immunol; 1988 Jul; 114(2):246-56. PubMed ID: 2455604 [TBL] [Abstract][Full Text] [Related]
4. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents. Leung KH; Koren HS J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. Linnemeyer PA; Pollack SB J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202 [TBL] [Abstract][Full Text] [Related]
6. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors. Rapp NS; Zenser TV; Mattammal MB; Davis BB J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824 [TBL] [Abstract][Full Text] [Related]
8. Modulation of human natural killer cell activity by pharmacological mediators. Hall TJ; Chen SH; Brostoff J; Lydyard PM Clin Exp Immunol; 1983 Nov; 54(2):493-500. PubMed ID: 6317242 [TBL] [Abstract][Full Text] [Related]
9. The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node. Gibson PR; Jewell DP Clin Exp Immunol; 1985 Jul; 61(1):160-8. PubMed ID: 2412737 [TBL] [Abstract][Full Text] [Related]
10. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor. Uchida A; Moore M J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944 [TBL] [Abstract][Full Text] [Related]
11. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2. Leung KH; Koren HS J Immunol; 1982 Oct; 129(4):1742-7. PubMed ID: 6180022 [TBL] [Abstract][Full Text] [Related]
12. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. Ramstedt U; Ng J; Wigzell H; Serhan CN; Samuelsson B J Immunol; 1985 Nov; 135(5):3434-8. PubMed ID: 2995494 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients. Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546 [TBL] [Abstract][Full Text] [Related]
14. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. Reynolds CW; Timonen T; Herberman RB J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744 [TBL] [Abstract][Full Text] [Related]
15. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity. Gatti G; Cavallo R; Sartori ML; Marinone C; Angeli A Immunopharmacology; 1986 Apr; 11(2):119-28. PubMed ID: 2423476 [TBL] [Abstract][Full Text] [Related]
16. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells. Vose BM; Bonnard GD J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes. Herman J; Rabson AR Clin Exp Immunol; 1984 Aug; 57(2):380-4. PubMed ID: 6331926 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of prostaglandin synthetase inhibitors on prostaglandin E2 binding and on prostaglandin- or cholera toxin-induced cyclic AMP accumulation in the rabbit uterus. Zor U; Koch R; Naor Z Adv Prostaglandin Thromboxane Res; 1976; 1():331-5. PubMed ID: 187046 [TBL] [Abstract][Full Text] [Related]
19. Modulation of cyclic 3'5'-adenosine monophosphate in cultured renal (MDCK) cells by endogenous prostaglandins. Hassid A J Cell Physiol; 1983 Sep; 116(3):297-302. PubMed ID: 6309869 [TBL] [Abstract][Full Text] [Related]